SAN JOSE, Calif., July 31, 2019 /PRNewswire-PRWeb/ -- Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of the next generation of its FLIPR® Penta ...

The adult human heart ventricle consists of cardiomyocytes, fibroblasts, endothelial cells, and other types of supporting cells. Despite cardiomyocytes being 75% of the total volume of the human ...

The industry-leading kinetic screening platform, developed on the success of supporting GPCR and membrane potential assays, provides researchers with a real-time screening of human-derived induced ...

The accelerating pace of drug discovery has spawned an increasing need for functional assays using living cells. Automating these assays for high-throughput systems, however, has proven to be ...

Molecular Devices, at SLAS 2015, launched a homogeneous, no-wash assay to measure ligand- and voltage-gated potassium channel activity. The FLIPR® Potassium Assay Kit uses a novel thallium-sensitive ...